Skip to main content

Animations

MJFF Publications

2691 - 2700 of 9036 Results
Title
Year
  • Year
  • 2022
  • 2023
  • 2020
  • 2020
  • 2025
  • 2021
  • 2021
  • 2021
  • 2020
  • 2021
  • Summary Details
    OPEN
    Title: Suitability of Automated Writing Measures for Clinical Trial Outcome in Writer's Cramp
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29237
    Citation Count: 8
  • Summary Details
    OPEN
    Title: PINK1-Dependent Mitophagy Inhibits Elevated Ubiquitin Phosphorylation Caused by Mitochondrial Damage
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.3c00555
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Purification of Recombinant α-synuclein: A Comparison of Commonly Used Protocols
    Journal Name: Biochemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acs.biochem.0c00725
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Observation of an α-synuclein liquid droplet state and its maturation into Lewy body-like assemblies
    Journal Name: Journal of Molecular Cell Biology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/jmcb/mjaa075
    Citation Count: 103
  • Summary Details
    OPEN
    Title: Astrocytic RNA editing regulates the host immune response to alpha-synuclein
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adp8504
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Global ubiquitylation analysis of mitochondria in primary neurons identifies endogenous Parkin targets following activation of PINK1
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.abj0722
    Citation Count: 72
  • Summary Details
    OPEN
    Title: The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00162-1
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Characterizing Advanced Parkinson’s Disease: Romanian Subanalysis from the OBSERVE-PD Study
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2021/6635618
    Citation Count: 21
  • Summary Details
    OPEN
    Title: BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-020-00965-9
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Deubiquitinating enzyme amino acid profiling reveals a class of ubiquitin esterases
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2006947118
    Citation Count: 87
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.